Navigation Links
Promising medical trainees receive funding to pursue research in hematology
Date:7/13/2009

(WASHINGTON, July 13, 2009) The American Society of Hematology (ASH) announces the 2009 recipients of its Trainee Research Awards. Through this program, which is designed to encourage the pursuit of research and spark an interest in hematology, 40 medical students, undergraduates, and residents will each receive $4,000 to conduct research on blood and blood-related diseases.

In addition, each award winner is provided with travel stipends to attend the ASH annual meeting, one of the largest medical meetings in the country. The meeting, held each December, provides important opportunities to meet other researchers as well as hear the latest scientific developments in the specialty.

Since 1995, Trainee Research Awards have supported more than 600 trainees early in their scientific careers. The funding is distributed through hematology training programs at the awardees' institutions and supports three-month-long projects in laboratory research or clinical investigation.

The 2009 ASH Trainee Research Award recipients are:

  • Manish Aggarwal, BS, University of Iowa College of Medicine
  • Karen Autio, MD, University of Virginia
  • Frederick Bartholomew, Duke University Medical Center
  • Ilan Bernstein, MD, Keck School at University of Southern California
  • Noah Birch, BS, Loyola University Chicago Stritch School of Medicine
  • Jocelyn Bosco, BS, Brigham and Women's Hospital
  • Toni Burbidge, Queens University
  • Sajiv Chandradas, BA, Mount Sinai School of Medicine
  • Carol Cheng, Duke University Medical Center
  • Ethan Cheng, Stanford University
  • Han-Yu Chuang, PhD, University of California, San Diego
  • Gordon Cohen, BA, Johns Hopkins University
  • Helena Dhamko, BSc, Princess Margaret Hospital
  • Laura DiNardo, BS, University of Pennsylvania
  • Daniel Dworkis, ScB, Boston University School of Medicine
  • Lydia Fein, University of Miami Miller School of Medicine
  • Jeff Friesen, University of Texas M. D. Anderson Cancer Center
  • Megan Gauthier, Washington University in St. Louis School of Medicine
  • Sarah Goldstein, Duke University Medical Center
  • Joe Huang, MD, University of Washington
  • Markus Jackson, Yale University
  • David Joung, BS, The Children's Hospital, Denver
  • Cigall Kadoch, BA, University of California, San Francisco
  • David Knorr, BS, University of Minnesota
  • Catherine Laiosa, MD, PhD, Mount Sinai School of Medicine
  • John Leschke, BA, Medical College of Wisconsin
  • Yedda Li, Washington University in St. Louis
  • Qiyuan Liu, PhD, H. Lee Moffitt Cancer Center
  • Chonyang Lu, BS, Children's Hospital of Philadelphia
  • Rui Mao, Baylor College of Medicine
  • Andrew Marshall, Fox Chase Cancer Center
  • Laura Myers, BA, Harvard Medical School, Brigham and Women's Hospital
  • Jay Patel, BA, Memorial Sloan Kettering Cancer Center
  • Siayareh Rambally, BS, Baylor College of Medicine
  • Katherine Ryken, University of Iowa College of Medicine
  • Umar Salimi, BA, University of Pittsburgh
  • Martin Schroeder, BS, University of Minnesota
  • Mazyar Shadman, MD, MPH, Cleveland Clinic Foundation
  • Gloria Shan, BS, University of Michigan
  • Leyla Shune, MD, University of Minnesota
  • Marko Skrtic, BSc, Sunnybrook Health Sciences Centre - Toronto Sunnybrook Regional Cancer Center
  • Kathleen Soltis, Brigham and Women's Hospital
  • Courtney Sorensen, BA, University of North Carolina School of Medicine
  • Zhu Wang, University of Pennsylvania
  • David Yao, BS, Case Western Reserve University and University Hospitals Case Medical Center


'/>"/>

Contact: Patrick C. Irelan
pirelan@hematology.org
202-776-0544
American Society of Hematology
Source:Eurekalert

Related medicine news :

1. Promising hematologists begin year-long program to pursue careers in clinical research
2. Mount Sinai researchers find new Alzheimers disease treatment promising
3. Pistachio Industry Looks Toward a Promising 2009 Crop Year
4. Delawares Partnership to Fight Chronic Disease Breakfast Highlights Promising Practices in Managing Chronic Disease Provides Solutions for Reduced Spending and Improved Patient Health
5. Boston Heart Lab Named Most Promising Early Stage Company 2009 by Silicom Ventures
6. New Drug Promising Against Rheumatoid Arthritis
7. Respiratory Rally a Promising Practice in the Fight Against Chronic Disease
8. Promising Therapy for Prostate Cancer
9. Promising biomarker and candidate tumor suppressor gene identified for colorectal cancer
10. AGH Joins Select Group of Medical Centers in Study of Promising New Technology for Treatment of Heart Failure
11. 17 of Americas Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians to create ... it streamlines the reporting process and provides a familiar interface that does not ...
(Date:4/28/2017)... ... ... sleep affects much more than energy – it also has mental and physical benefits. According ... reaction time, which can increase the risk of having a car accident. , This ... NSF to help you sleep better and feel better:, , Turn ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... exposed to more adverse experiences than children in the general population. That’s because ... abuse, neglect or other family challenges. While no fault of their own, youth ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection ... improve drug safety and minimize the cost of development. In this webinar, sponsored ... using cell lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... 20, 2017   ZappRx, Inc ., a digital health ... process, today announced it closed $25 million in Series B ... firm based in Seattle that is ... . The Series B round included participation from SR ... and GV (formerly Google Ventures). As part of ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: